Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

High Burden of Invasive Fungal Infection in Korean Pediatric Liver Transplant Recipients: A Single-Center Retrospective Cohort Study (2012-2023).

Created on 24 Jul 2026

Authors

Ji Young Lee, Jee Yeon Baek, Hong Koh, Myoung Soo Kim, Jong Gyun Ahn, Kyong Ihn, Ji-Man Kang

Published in

Yonsei medical journal. Volume 67. Issue 8. Pages 593-602.

Abstract

The incidence of invasive fungal infection (IFI) in pediatric liver transplant (LT) recipients in Korea has not been characterized; consequently, antifungal prophylaxis is not covered by the national health insurance. We aimed to determine the incidence and epidemiology of IFI.
We conducted a single-center, retrospective study of children (age ≤19 years) who underwent LT at Severance Children's Hospital, Republic of Korea (2012-2023). IFI was defined as fungal isolation from a sterile site (fluid/blood/tissue) with compatible clinical features.
Of the 126 LT cases involving 115 children, 69.0% (n=87) were performed due to biliary atresia. Twenty-four IFI episodes in 20 recipients yielded a 90-day post-LT crude incidence of 19.0% and an incidence rate of 0.14 per 1000 patient-days. Invasive candidiasis predominated (95.4%) with Candida albicans (40.9%), C. parapsilosis (31.8%), and C. auris (9.1%). The most common clinical manifestations were peritonitis (54.2%) and fungemia (16.7%). Emergency LT [subdistribution hazard ratio (sHR), 3.97; 95% confidence interval (CI), 1.39-11.3; p=0.010] and reoperation or interventional procedures (sHR, 4.05; 95% CI, 1.53-10.7; p=0.005) were independently associated with IFI. One-year overall survival was significantly lower in the IFI group than in the non-IFI group (58.4% vs. 82.8%, p=0.037).
IFIs impose a burden on pediatric LT recipients in Korea and are associated with poorer survival. These data support the consideration of universal antifungal prophylaxis. However, multicenter studies are warranted to validate these findings and define the prophylaxis regimen.

PMID:
42494267
Bibliographic data and abstract were imported from PubMed on 24 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement